Natixis Advisors LLC Increases Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)
Natixis Advisors LLC lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 69.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,153 shares of the biotechnology company’s stock after buying an additional 11,900 shares during […]
